MetrioPharm (Germany)
MetrioPharm is a clinical-stage company at the forefront of developing safer and more effective treatments based on first-in-class self-regulating immunomodulators for inflammatory and infectious diseases.
Basic Information
- Category: business
- Website: http://www.metriopharm.com/
Documented Facts
- Inception (Wikidata): 2007 (Source 3: Wikidata Q30269118, revision 2474178020)
- Country (Wikidata; date unspecified): Germany (Source 3: Wikidata Q30269118, revision 2474178020; Source 4: Wikidata label: Q183, revision 2557182420)
- Official website (Wikidata; date unspecified): http://www.metriopharm.com/ (Source 3: Wikidata Q30269118, revision 2474178020)
Evidence and Sources
- MetrioPharm (Germany) — Official Site (official)
- MetrioPharm (Germany) on linkedin (social)
- Wikidata Q30269118, revision 2474178020 (knowledge-base)
- Wikidata label: Q183, revision 2557182420 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about MetrioPharm (Germany).
- Canonical profile: https://brandsource.ai/brands/metriopharm-germany
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/metriopharm-germany/json-ld
- Citation profile API: https://brandsource.ai/api/brands/metriopharm-germany/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Partial
- Profile completeness: Source-backed profile (86/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
MetrioPharm is a clinical-stage company at the forefront of developing safer and more effective treatments based on first-in-class self-regulating immunomodulators for inflammatory and infectious diseases.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
Known data gaps
- Profile enrichment is incomplete
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.